Sfoglia per Autore
Plateau phase in multiple myeloma: an end-point of conventional-dose chemotherapy
1999-01-01 Corso, A; Nozza, A; Lazzarino, A; Klersy, C; Zappasodi, P; Arcaini, Luca; Bernasconi, C.
Transient response of myeloma clone to pamidronate therapy
1999-01-01 Corso, A; Astori, C; Orlandi, E; Zappasodi, P; Arcaini, Luca; Bernasconi, C.
The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders
1999-01-01 Lazzarino, M; Orlandi, E; Baldanti, Fausto; Furione, M; Pagnucco, G; Astori, C; Arcaini, Luca; Viglio, A; Paulli, Marco; Gerna, G; Bernasconi, C.
Il ruolo del trapianto autologo nei linfomi non-Hodgkin indolenti
2000-01-01 Lazzarino, Mario; Arcaini, Luca; Bernasconi, Paolo; Orlandi, Ester; Astori, Cesare; Pagnucco, Guido; Alessandrino Emilio, Paolo; Bernasconi, Carlo
Effects of breathing control on cardiocirculatory modulation in Caucasian lowlanders and Himalayan Sherpas
2000-01-01 Keyl, C; Schneider, A; Greene, Re; Passino, C; Spadacini, G; Bandinelli, G; Bonfichi, M; Arcaini, Luca; Malcovati, Luca; Bernardi, L.
Haematological modifications after acute exposure to high altitude: possible implications for detenction of recombinant erythropoietin misure
2000-01-01 Bernardi, Luciano; Bonfichi, M; Balduini, Alessandra; Arcaini, Luca; Marseglia, C; Malcovati, Luca; Passino, C; Spandacini, G; Feli, P; Keyl, C; Schneider, A; Boiardi, A; Bandinelli, G; Greene, Re; Bernasconi, C.
Rituximab (IDEC-C2B8): validation of a sensitive enzyme-linked immunoassay applied to a clinical pharmacokinetic study
2000-01-01 Iacona, I; Lazzarino, M; Avanzini, Ma; Rupolo, M; Arcaini, Luca; Astori, C; Lunghi, F; Orlandi, E; Morra, E; Zagonel, V; Regazzi, Mb
Haematological modifications after acute exposure to high altitude: possible implications for detection of recombinant erythropoietin misuse
2000-01-01 Bonfichi, M; Balduini, Alessandra; Arcaini, Luca; Lorenzi, A; Marseglia, C; Malcovati, Luca; Bernardi, L; Passino, C; Spandacini, G; Feil, P; Keyl, C; Schneider, A; Boiardi, A; Bandinelli, G; Greene, Re; Bernasconi, C.
Peripheral arterial vascular function at altitude: sea-level natives versus Himalayan high-altitude natives
2001-01-01 Schneider, A; Greene, Re; Keyl, C; Bandinelli, G; Passino, C; Spadacini, G; Bonfichi, M; Arcaini, Luca; Malcovati, Luca; Boiardi, A; Feil, P; Bernardi, L.
Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients
2001-01-01 Corso, A; Arcaini, Luca; Mangiacavalli, S; Astori, C; Orlandi, E; Lorenzi, A; Passamonti, F; Klersy, C; Pascutto, C; Canevari Sciorati, A; Lazzarino, M.
A young woman with microcytic anemia and hypertransaminasemia
2001-01-01 Arcaini, Luca; Cerani, P; Lorenzi, A; Lazzarino, Mario
A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and nontoxic treatment for advanced follicular and mantle cell lymphoma
2002-01-01 Lazzarino, M; Arcaini, Luca; Bernasconi, Paolo; Alessandrino, Ep; Gargantini, L; Cairoli, R; Orlandi, E; Astori, C; Brusamolino, E; Pagnucco, G; Colombo, Aa; Calatroni, S; Iacona, I; Regazzi, M; Morra, E.
A combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin is less toxic and more effective than high-dose cyclophosphamide for peripheral stem cell mobilization in multiple myeloma.
2002-01-01 Corso, A; Arcaini, Luca; Caberlon, S; Zappasodi, P; Mangiacavalli, S; Lorenzi, A; Rusconi, C; Troletti, D; Maiocchi, Ma; Pascutto, C; Morra, E; Lazzarino, M.
Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma
2002-01-01 Rambaldi, A; Lazzari, M; Manzoni, C; Carlotti, E; Arcaini, Luca; Baccarani, M; Barbui, T; Bernasconi, C; Dastoli, G; Fuga, G; Gamba, E; Gargantini, L; Gattei, V; Lauria, F; Lazzarino, M; Mandelli, F; Morra, E; Pulsoni, A; Ribersani, M; ., Rossi Ferrini PL; Rupolo, M; Tura, S; Zagonel, V; Zaja, F; Zinzani, P; Reato, G; Foa, R.
Eosinophilic folliculitis occurring in a patient affected by Hodgkin lymphoma.
2002-01-01 Vassallo, C; Ciocca, O; Arcaini, Luca; Borroni, Giovanni; Ardigò, M; Lazzarino, M; Borroni, G.
Marginal zone-related neoplasms of splenic and nodal origin
2003-01-01 Arcaini, Luca; Paulli, Marco; Boveri, E; Magrini, U; Lazzarino, M.
Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia.
2003-01-01 Passamonti, Francesco; Malabarba, L; Orlandi, E; Baratè, C; Canevari, A; Brusamolino, E; Bonfichi, M; Arcaini, Luca; Caberlon, S; Pascutto, Cristiana; Lazzarino, Mario
Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia
2004-01-01 Passamonti, Francesco; Rumi, Elisa; Pungolino, E; Malabarba, L; Bertazzoni, P; Valentini, M; Orlandi, E; Arcaini, Luca; Brusamolino, E; Pascutto, C; Cazzola, Mario; Morra, E; Lazzarino, Mario
Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman.
2004-01-01 Passamonti, Francesco; Rumi, Elisa; Malabarba, L; Arcaini, Luca; Orlandi, E; Brusamolino, E; Pascutto, C; Cazzola, Mario; Lazzarino, Mario
Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma.
2004-01-01 Arcaini, Luca; Orlandi, E; Scotti, M; Brusamolino, E; Passamonti, Francesco; Burcheri, S; Colombo, N; Vanelli, L; Sbalzarini, G; Lazzarino, Mario
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Plateau phase in multiple myeloma: an end-point of conventional-dose chemotherapy | 1-gen-1999 | Corso, A; Nozza, A; Lazzarino, A; Klersy, C; Zappasodi, P; Arcaini, Luca; Bernasconi, C. | |
Transient response of myeloma clone to pamidronate therapy | 1-gen-1999 | Corso, A; Astori, C; Orlandi, E; Zappasodi, P; Arcaini, Luca; Bernasconi, C. | |
The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders | 1-gen-1999 | Lazzarino, M; Orlandi, E; Baldanti, Fausto; Furione, M; Pagnucco, G; Astori, C; Arcaini, Luca; Viglio, A; Paulli, Marco; Gerna, G; Bernasconi, C. | |
Il ruolo del trapianto autologo nei linfomi non-Hodgkin indolenti | 1-gen-2000 | Lazzarino, Mario; Arcaini, Luca; Bernasconi, Paolo; Orlandi, Ester; Astori, Cesare; Pagnucco, Guido; Alessandrino Emilio, Paolo; Bernasconi, Carlo | |
Effects of breathing control on cardiocirculatory modulation in Caucasian lowlanders and Himalayan Sherpas | 1-gen-2000 | Keyl, C; Schneider, A; Greene, Re; Passino, C; Spadacini, G; Bandinelli, G; Bonfichi, M; Arcaini, Luca; Malcovati, Luca; Bernardi, L. | |
Haematological modifications after acute exposure to high altitude: possible implications for detenction of recombinant erythropoietin misure | 1-gen-2000 | Bernardi, Luciano; Bonfichi, M; Balduini, Alessandra; Arcaini, Luca; Marseglia, C; Malcovati, Luca; Passino, C; Spandacini, G; Feli, P; Keyl, C; Schneider, A; Boiardi, A; Bandinelli, G; Greene, Re; Bernasconi, C. | |
Rituximab (IDEC-C2B8): validation of a sensitive enzyme-linked immunoassay applied to a clinical pharmacokinetic study | 1-gen-2000 | Iacona, I; Lazzarino, M; Avanzini, Ma; Rupolo, M; Arcaini, Luca; Astori, C; Lunghi, F; Orlandi, E; Morra, E; Zagonel, V; Regazzi, Mb | |
Haematological modifications after acute exposure to high altitude: possible implications for detection of recombinant erythropoietin misuse | 1-gen-2000 | Bonfichi, M; Balduini, Alessandra; Arcaini, Luca; Lorenzi, A; Marseglia, C; Malcovati, Luca; Bernardi, L; Passino, C; Spandacini, G; Feil, P; Keyl, C; Schneider, A; Boiardi, A; Bandinelli, G; Greene, Re; Bernasconi, C. | |
Peripheral arterial vascular function at altitude: sea-level natives versus Himalayan high-altitude natives | 1-gen-2001 | Schneider, A; Greene, Re; Keyl, C; Bandinelli, G; Passino, C; Spadacini, G; Bonfichi, M; Arcaini, Luca; Malcovati, Luca; Boiardi, A; Feil, P; Bernardi, L. | |
Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients | 1-gen-2001 | Corso, A; Arcaini, Luca; Mangiacavalli, S; Astori, C; Orlandi, E; Lorenzi, A; Passamonti, F; Klersy, C; Pascutto, C; Canevari Sciorati, A; Lazzarino, M. | |
A young woman with microcytic anemia and hypertransaminasemia | 1-gen-2001 | Arcaini, Luca; Cerani, P; Lorenzi, A; Lazzarino, Mario | |
A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and nontoxic treatment for advanced follicular and mantle cell lymphoma | 1-gen-2002 | Lazzarino, M; Arcaini, Luca; Bernasconi, Paolo; Alessandrino, Ep; Gargantini, L; Cairoli, R; Orlandi, E; Astori, C; Brusamolino, E; Pagnucco, G; Colombo, Aa; Calatroni, S; Iacona, I; Regazzi, M; Morra, E. | |
A combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin is less toxic and more effective than high-dose cyclophosphamide for peripheral stem cell mobilization in multiple myeloma. | 1-gen-2002 | Corso, A; Arcaini, Luca; Caberlon, S; Zappasodi, P; Mangiacavalli, S; Lorenzi, A; Rusconi, C; Troletti, D; Maiocchi, Ma; Pascutto, C; Morra, E; Lazzarino, M. | |
Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma | 1-gen-2002 | Rambaldi, A; Lazzari, M; Manzoni, C; Carlotti, E; Arcaini, Luca; Baccarani, M; Barbui, T; Bernasconi, C; Dastoli, G; Fuga, G; Gamba, E; Gargantini, L; Gattei, V; Lauria, F; Lazzarino, M; Mandelli, F; Morra, E; Pulsoni, A; Ribersani, M; ., Rossi Ferrini PL; Rupolo, M; Tura, S; Zagonel, V; Zaja, F; Zinzani, P; Reato, G; Foa, R. | |
Eosinophilic folliculitis occurring in a patient affected by Hodgkin lymphoma. | 1-gen-2002 | Vassallo, C; Ciocca, O; Arcaini, Luca; Borroni, Giovanni; Ardigò, M; Lazzarino, M; Borroni, G. | |
Marginal zone-related neoplasms of splenic and nodal origin | 1-gen-2003 | Arcaini, Luca; Paulli, Marco; Boveri, E; Magrini, U; Lazzarino, M. | |
Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia. | 1-gen-2003 | Passamonti, Francesco; Malabarba, L; Orlandi, E; Baratè, C; Canevari, A; Brusamolino, E; Bonfichi, M; Arcaini, Luca; Caberlon, S; Pascutto, Cristiana; Lazzarino, Mario | |
Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia | 1-gen-2004 | Passamonti, Francesco; Rumi, Elisa; Pungolino, E; Malabarba, L; Bertazzoni, P; Valentini, M; Orlandi, E; Arcaini, Luca; Brusamolino, E; Pascutto, C; Cazzola, Mario; Morra, E; Lazzarino, Mario | |
Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman. | 1-gen-2004 | Passamonti, Francesco; Rumi, Elisa; Malabarba, L; Arcaini, Luca; Orlandi, E; Brusamolino, E; Pascutto, C; Cazzola, Mario; Lazzarino, Mario | |
Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma. | 1-gen-2004 | Arcaini, Luca; Orlandi, E; Scotti, M; Brusamolino, E; Passamonti, Francesco; Burcheri, S; Colombo, N; Vanelli, L; Sbalzarini, G; Lazzarino, Mario |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile